Literature DB >> 62825

[Selective muscle fiber type anomalies in neuromusclar disorders. An analysis of 124 consecutive muscle biopsies (author's transl)].

C Tosi, F Jerusalem.   

Abstract

The following parameters were measured and calculated in 124 consecutive muscle biopsies: mean fiber diameter, standard deviation, percentage of type I and Type II fibers, variability coefficient, hypertrophy and atrophy factor. Twenty percent of the histometrically analyzed biopsies showed a type II atrophy and four percent a type I atrophy. Type II atrophy was found particularly in the following disorders: collagen vascular diseases, steroid myopathies, cachexia and as a result of inactivity. Some neurogenic processes also demonstrated a selective type II atrophy. The combination of a grouped type II atrophy with a type I hypertrophy is characteristic of chronic and usually heredodegenerative disorders of the motoneurons. The presence of a selective type II atrophy argues against a genetically determined muscular dystrophy. A mixed atrophy classified here as strong or very strong primarily suggests a neuropathy. A selective type I hypertrophy has been found exclusively in neurogenic processes, and type II hypertrophy predominantly in the cases of chronic heredodegenerative neurogenic and primarily myopathic diseases. An increase of the variability coefficient of both types of muscle fibers is more frequent and pronounced in neurogenic processes than in myopathic syndromes. Type II fibers show a selective increase in the variability coefficient considerably more often than type I fibers. In contrast to other reports we seldom found a fiber type predominance or a pathological type-grouping. Only two out of five biopsies with pathological fiber type-grouping were definitely neurogenic. In special cases the histometric analysis of muscle fiber types improves the diagnostic efficiency of muscle biopsies.

Entities:  

Mesh:

Year:  1976        PMID: 62825     DOI: 10.1007/BF00313486

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Familial type I fiber atrophy.

Authors:  M Kinoshita; E Satoyoshi; M Kumagai
Journal:  J Neurol Sci       Date:  1975-05       Impact factor: 3.181

2.  The sizes of the two main histochemical fibre types in five limb muscles in man. An autopsy study.

Authors:  F G Jennekens; B E Tomlinson; J N Walton
Journal:  J Neurol Sci       Date:  1971-07       Impact factor: 3.181

3.  Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases.

Authors:  W K Engel; M H Brooke; P G Nelson
Journal:  Ann N Y Acad Sci       Date:  1966-09-09       Impact factor: 5.691

4.  Type I fiber atrophy and nemaline bodies.

Authors:  M Kinoshita; E Satoyoshi
Journal:  Arch Neurol       Date:  1974-12

5.  Steroid myopathy. Clinical, histologic and cytologic observations.

Authors:  A K Afifi; R A Bergman; J C Harvey
Journal:  Johns Hopkins Med J       Date:  1968-10

6.  Cerebral influence on muscle fiber typing. The effect of fetal immobilization.

Authors:  G M Fenichel
Journal:  Arch Neurol       Date:  1969-06

7.  The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female.

Authors:  M H Brooke; W K Engel
Journal:  Neurology       Date:  1969-03       Impact factor: 9.910

8.  Neuromuscular disease with type I fiber atrophy, central nuclei, and myotube-like structures.

Authors:  J Bethlem; G K van Wijngaarden; A E Meijer; W C Hülsmann
Journal:  Neurology       Date:  1969-07       Impact factor: 9.910

9.  [Technic of muscle biopsy].

Authors:  F Jerusalem; R Bischhausen
Journal:  Nervenarzt       Date:  1975-01       Impact factor: 1.214

10.  Fibre hybrids in type groups. An investigation of human muscle biopsies.

Authors:  F G Jennekens; A E Meijer; J Bethlem; G K Van Wijngaarden
Journal:  J Neurol Sci       Date:  1974-11       Impact factor: 3.181

View more
  6 in total

1.  Myopathology of myotonic dystrophy. A morphometric study.

Authors:  G Casanova; F Jerusalem
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

2.  Metabolic substrates, muscle fibre composition and fibre size in late walking and normal children.

Authors:  A Lundberg; B O Eriksson; G Mellgren
Journal:  Eur J Pediatr       Date:  1979-02-08       Impact factor: 3.183

3.  Quantitative analysis of voluntary muscles from routine autopsy material with special reference to the problem of remote carcinomatous changes ("neuromyopathy").

Authors:  H P Schmitt
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

4.  Muscle abnormalities in coeliac disease: studies on gross motor development and muscle fibre composition, size and metabolic substrates.

Authors:  A Lundberg; B O Eriksson; G Jansson
Journal:  Eur J Pediatr       Date:  1979-02-08       Impact factor: 3.183

5.  Additional biochemical criteria in the differential diagnosis of myositis.

Authors:  C W Zimmermann; H D Langohr; H Wiethölter; J Peiffer
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

6.  RNA-seq and metabolomic analyses of Akt1-mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome.

Authors:  Chia-Ling Wu; Yoshinori Satomi; Kenneth Walsh
Journal:  BMC Genomics       Date:  2017-02-16       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.